[Treatment of epistaxis in Rendu-Osler disease by intramucosal injection of ethibloc]

M Borsik; D Herbreteau; D Deffrennes; J P Guichard; A Aymard; J J Merland; P Tran Ba Huy

[Treatment of epistaxis in Rendu-Osler disease by intramucosal injection of ethibloc]

Ann Otolaryngol Chir Cervicofac. 1992;109(5):273-6.

[Article in French]

Authors

M Borsik¹, D Herbreteau, D Deffrennes, J P Guichard, A Aymard, J J Merland, P Tran Ba Huy

Affiliation

¹ Service ORL, Hôpital Lariboisière, Paris.

PMID: 1292384

Abstract

The authors relate their one-year experience in percutaneous embolization of 12 patients presenting with severe epistaxis because of a Rendu Osler disease. Using Ethibloc a sclerosing substance derived from maize in direct intramucosal injection seems to be a promising technique. Ethibloc is still used successfully in percutaneous treatment of superficial venous angiomas.

Publication types

English Abstract

MeSH terms

Adult
Aged
Diatrizoate*
Drug Combinations
Embolization, Therapeutic / methods*
Epistaxis / etiology
Epistaxis / therapy*
Fatty Acids*
Female
Humans
Male
Middle Aged
Propylene Glycols*
Proteins / therapeutic use*
Retrospective Studies
Sclerosing Solutions
Telangiectasia, Hereditary Hemorrhagic / complications
Telangiectasia, Hereditary Hemorrhagic / therapy*
Zein*

Substances

Drug Combinations
Fatty Acids
Propylene Glycols
Proteins
Sclerosing Solutions
Diatrizoate
Zein
alcoholic prolamine solution